The PressureWire fractional flow reserve measurement system for coronary artery disease

References

Bech GJW, De Bruyne B, Bonnier HJR M et al. (1998) Long-Term Follow-Up After Deferral of Percutaneous Transluminal Coronary Angioplasty of Intermediate Stenosis on the Basis of Coronary Pressure Measurement. Journal of the American College of Cardiology 31: 841–847

Bech, GJ, De Bruyne B, Pijls NH et al. (2001a) Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 103: 2928–2934

Bech GJW, Droste H, Pijls NH et al. (2001b) Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart 86: 547–552

Blue Cross and Blue Shield Association Technology Evaluation Center (2011) Fractional flow reserve and coronary artery revascularization, Report 26

Boden W. (2012) Which Is More Enduring — FAME or COURAGE? The New England Journal of Medicine 367: 1059–1061

Bornschein B, Arvandi M, Gothe R et al. (2011) Cost effectiveness of fractional flow reserve measurement in multivessel coronary artery disease in Belgium and France. Value in Health 14: A233–A510

Botman KJ, Pijls NH, Bech JW et al. (2004) Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement. Catheterization and Cardiovascular Interventions 63: 184–191

Carrick D, Behan M, Foo F et al. (2011) Influence of fractional flow reserve measurement on treatment-decisions in patients with recent acute non-ST elevation myocardial infarction. Heart 97: A16–A17

Carrick D, Behan M, Foo F et al. (2013) Usefulness of Fractional Flow Reserve to Improve Diagnostic Efficiency in Patients With Non-ST Elevation Myocardial Infarction. The American Journal of Cardiology 111: 45–50

Chamuleau SAJ, Meuwissen M, Koch KT et al. (2002) Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. The American Journal of Cardiology 89: 377–380

Dambrink JH, Debrauwere JP, Van 't Hof AWJ et al. (2010) Non-culprit lesions detected during primary PCI: Treat invasively or follow the guidelines? EuroIntervention 5: 968-975

Dawkins KD, Gershlick T, de Belder M et al. (2005) Percutaneous coronary intervention: recommendations for good practice and training. Heart 91: vi1–vi27

De Bruyne B, Pijls NH, Kalesan B et al. (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. New England Journal of Medicine 367: 991–1001

Fearon WF, Bornschein B, Tonino PA et al. (2010) Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation 122: 2545–2550

Fearon WF, Shilane D, Pijls NH et al. (2013) Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. Circulation 128: 17: 1335-1340

Fearon WF, Tonino PA, De Bruyne B et al. (2007) Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) study. American Heart Journal 154: 632–636

Fearon WF, Yeung AC, Lee DP et al. (2003) Cost-effectiveness of measuring fractional flow reserve to guide coronary interventions. American Heart Journal 145: 882–887

Ghani A, Dambrink JH, Van't Hof AWJ et al. (2012) Treatment of non-culprit lesions detected during primary PCI: Long-term follow-up of a randomised clinical trial. Netherlands Heart Journal 20: 347–353

Health & Social Care Information Centre. HRG4 2014/15. Consultation Grouper HRG4 Chapter Summaries. [Accessed 16th January 2014]

Hernandez-Garcia JM, Alonso-Briales JH, Jimenez-Navarro M et al. (2001) Clinical Management of Patients with Coronary Syndromes and Negative Fractional Flow Reserve Findings. Journal of Interventional Cardiology 14: 505–510

Hoole SP, Seddon MD, Poulter RS et al. (2011) Fame comes at a cost: a Canadian analysis of procedural costs in use of pressure wire to guide multivessel percutaneous coronary intervention. Canadian Journal of Cardiology 27: 2: 262.e1–262.e2

Jasti V, Ivan E, Yalamanchili V, et al. (2004) Correlations Between Fractional Flow Reserve and Intravascular Ultrasound in Patients With an Ambiguous Left Main Coronary Artery Stenosis. Circulation 110: 2831–2836

Jimenez-Navarro M, Hernandez-Garcia JM, Alonso-Briales JH et al. (2004) Should we treat patients with moderately severe stenosis of the left main coronary artery and negative FFR results? Journal of Invasive Cardiology 16: 398–400

Kim HS, Tonino PA, De Bruyne Bet al. (2012) The impact of sex differences on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) substudy. JACC.Cardiovascular Interventions 5: 1037–1042

Leesar MA, Abdul-Baki T, Akkus NI et al. (2003) Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina. Effect on duration of hospitalization, cost, procedural characteristics, and clinical outcome. Journal of the American College of Cardiology 41: 1115–1121

Legalery P, Schiele F, Seronde MF et al. (2005) One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty. European Heart Journal 26: 2623–2629

Li J, Elrashidi MY, Flammer AJ et al. (2013) Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. European Heart Journal 34: 1375–1383

Lindstaedt M, Yazar A, Germing A et al. (2006) Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements. American Heart Journal 152: 15

Lopez-Palop R, Pinar E, Lozano I et al. (2004) Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis. European Heart Journal 25: 2040–2047 

Ludman, P (2013a) BCIS Audit Returns 2012: adult interventional procedures

Ludman, P (2013b) National Audit of Percutaneous Coronary Interventional Procedures: annual public report (January 2011–December 2011), National Institute for Cardiovascular Outcomes Research (NICOR)

Medical Services Advisory Committee (MSAC) (2005) Coronary pressure wire: MSAC application 1080.

Meuwissen M, de Winter RJ, Chamuleau SAJ et al. (2003) Value of C-reactive protein in patients with stable angina pectoris, coronary narrowing (30% to 70%), and normal fractional flow reserve. The American Journal of Cardiology 92: 702–705

Montalescot G, Sechtem U, Achenbach Set al. (2013) ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal 34: 2949–3003

Muramatsu T, Tsukahara R, Ho M et al. (2002) Usefulness of fractional flow reserve guidance for PCI in acute myocardial infarction. The Journal of Invasive Cardiology 14: 657–662

Nam CW, Mangiacapra F, Entjes et al. (2011) Functional SYNTAX score for risk assessment in multivessel coronary artery disease. Journal of the American College of Cardiology 58: 1211–1218

National Institute for Health and Clinical Excellence (2012) Management of stable angina NICE clinical guideline 126

National Institute for Health and Clinical Excellence (2010) Unstable angina and NSTEMI. NICE clinical guideline 94 

Ozdemir M, Timurkaynak T, Cemri M et al. (2002). Medium-term follow-up of intermediate coronary stenoses left unrevascularized based on myocardial fractional flow reserve findings. Acta Cardiologica 57: 335–340

Patel MR (2013) Fractional Flow Reserve and the Appropriate Use Criteria: determining best practices in coronary revascularization. Cardiac Interventions Today Jan–Feb 2013: 64–74

Patel MR, Bailey SR, Bonow RO et al. (2012). Appropriate Use Criteria for Diagnostic Catheterization: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force. Journal of the American College of Cardiology 59: 1995–2027

Pijls NH, De Bruyne B, Peels K et al. (1996) Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. New England Journal of Medicine 334: 1703–1708

Pijls NH, Fearon WF, Tonino PA et al. (2010) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. Journal of the American College of Cardiology 56: 177–184

Pijls NH, van Schaardenburgh P, Manoharan G et al. (2007) Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. Journal of the American College of Cardiology 49: 2105–2111

Raman G, Yu W, Ip S et al. (2013) Intravascular diagnostic procedures and imaging techniques versus angiography alone in coronary artery stenting: comparative effectiveness review. 104

Reczuch K, Jankowska E, Telichowski A et al. (2004) Measurement of fractional flow reserve in patients with multi-vessel coronary artery disease and borderline lesions prevents unnecessary revascularisation procedures. Kardiologia Polska 60: 311–319

Rieber J, Schiele TM, Koenig A et al. (2002) Long-term safety of therapy stratification in patients with intermediate coronary lesions based on intracoronary pressure measurements. The American Journal of Cardiology 90: 1160–1164

Sels JW, Tonino PA, Siebert U et al. (2011) Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC: Cardiovascular Interventions 4:1183–1189 

Siebert U, Bornschein B, Arvandi MS et al. (2011a). Cost-effectiveness and public health/budget-impact of ffr-guided PCI in multivessel patients in 6 European countries – analysis along the FAME trial data. Society for Medical Decision Making (SMDM) 33^rd Annual Meeting

Siebert U, Bornschein B, Arvandi MS et al. (2011b) Cost-effectiveness and public health and budget-impact of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease in Germany. Health Technology Assessment Society (HTAi) 8th Annual Meeting

Siebert U, Bornschein B, Schnell-Inderst P et al. (2008) Measurement of fractional flow reserve to guide decisions for percutaneous coronary intervention. GMS Health Technology Assessment 4: 7

Tonino PA, De Bruyne B, Pijls NH et al. (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. New England Journal of Medicine 360: 213–224

Tonino PA, Fearon WF, De Bruyne Bet al. (2010) Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. Journal of the American College of Cardiology 55: 2816–2821

Wijns W, Kolh P, Danchin Net al. (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 31: 2501–2555

Wongpraparut N, Yalamanchili V, Pasnoori Vet al. (2005) Thirty-month outcome after fractional flow reserve-guided versus conventional multivessel percutaneous coronary intervention. American Journal of Cardiology 96: 877–884